Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2018/0154035 DEVICE FOR CONTROLLED RELEASE OF FLUID
Delivery devices 100 for controlled discharge of a volatile fluid 118 at a relatively constant rate over a sustained period of time. Volatile fluid 118 may be...
2018/0154034 SWITCHABLE GAS AND LIQUID RELEASE AND DELIVERY DEVICES, SYSTEMS, AND METHODS
Methods, systems, and devices are disclosed for implementing switchable dispensing and/or delivery of scented substances. In one aspect, a device includes a...
2018/0154033 PHASE-STABLE, SPRAYABLE FRESHENING COMPOSITIONS COMPRISING SUSPENDED PARTICLES
A freshening composition is provided. The composition includes at least one particle, and an aqueous carrier. The composition includes a polysaccharide system...
2018/0154032 SYSTEM AND APPARATUS THEREOF FOR DESTROYING PATHOGENS ASSOCIATED WITH FOOTWEAR
An apparatus for destroying pathogens includes a platform and an LED matrix panel. The platform has a portion configured to permit passage of ultraviolet light...
2018/0154031 METHOD OF STERILIZATION OF MICROPARTICLES
Methods of sterilizing microparticles using a porous solid matrix which allows penetration of a sterilizing gas such as EtO to pass through are disclosed. The...
2018/0154030 System and Method For Sterilizing and/or Deimmunizing an Object
A system for sterilizing and/or deimmunizing an object includes a stationary chamber at ambient pressure is configured to store an object to be sterilized...
2018/0154029 STERILIZING DEVICE AND MANUFACTURING METHOD FOR STERILIZING DEVICE
A sterilizing device comprises a light guiding member and an ultraviolet (UV) light source. The light guiding member has a surface. The UV light source emits...
2018/0154028 BAGS FOR SANITIZING CONTENTS USING OZONE AND ULTRAVIOLET LIGHT
A portable bag may comprise a body having one or more compartments each sized to receive an article of clothing. The bag may include an access channel that is...
2018/0154027 Inactivation Of Gram-Positive Bacteria
A method for inactivating medically important Gram-positive bacteria including Methicillin-resistant Staphylococcus aureus (MRSA), Coagulase-Negative...
2018/0154026 METHOD FOR STERILIZING MEMBRANE COMPRISING GLUCOSE OXIDASE AND ASSOCIATED BIO-SENSOR
A method for sterilizing a membrane comprising an oxidoreductase enzyme, comprises: irradiating with gamma radiation the membrane comprising an oxidoreductase...
2018/0154025 HYDROPHILIC FLUORINATED MOLECULES FOR LIPOSOMAL 19F MRI PROBES WITH UNIQUE MR SIGNATURES
Readily available hydrophilic and small organofluorine moieties were condensed via "click chemistry" to generate nonionic hydrophilic fluorinated molecules...
2018/0154024 COMPOSITES AND COMPOSITIONS FOR THERAPEUTIC USE AND METHODS OF MAKING AND USING THE SAME
Disclosed herein are embodiments of composites and compositions that can be used for therapeutic applications in vivo and/or in vitro. The disclosed composites...
2018/0154023 NUCLEIC ACID-CATIONIC POLYMER COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
Provided herein are pre-lyophilized compositions containing a nucleic acid, a cationic polymer, and a carbohydrate. Also provided are lyophilized compositions...
2018/0154022 PROMOTERS, EXPRESSION CASSETTES, VECTORS, KITS, AND METHODS FOR THE TREATMENT OF ACHROMATOPSIA AND OTHER DISEASES
The present invention provides isolated promoters, transgene expression cassettes, vectors, kits, and methods for treatment of genetic diseases that affect the...
2018/0154021 MAGNETIC CELLS FOR LOCALIZING DELIVERY AND TISSUE REPAIR
Normal or genetically modified cell(s) having magnetic nanoparticle(s) bound (affixed) to their surfaces and methods of delivery to target tissues, e.g. for...
2018/0154020 METHOD OF ATTACKING TARGET CELLS
A method of killing cells of a targeted cell type in a patient body that utilizes nanoparticles (10) having a first portion (12), which when exposed to a...
2018/0154019 COMPOSITIONS AND METHODS FOR ADMINISTERING ANTIBODIES
The present invention relates to a drug delivery system and uses thereof. Specifically, a system that can be used to deliver therapeutic proteins, including...
2018/0154018 PEPTIDE-CONTAINING LINKERS FOR ANTIBODY-DRUG CONJUGATES
The present disclosure relates generally to antibody-drug conjugates comprising peptide-containing linkers and to methods of using these conjugates as...
2018/0154017 ANTIBODIES
Antibodies having modified constant regions so as to permit conjugation of the antibody to a payload such as a therapeutic agent are described. Preferred...
2018/0154016 DE-N-Acetyl Sialic Acid Antigens, Antibodies Thereto, and Methods of Use in Cancer Therapy
The present invention generally provides compositions methods and composition relating to the diagnosis and/or treatment of cancers having a cell surface...
2018/0154015 INHALANT FORMULATION CONTAINING SULFOALKYL ETHER CYCLODEXTRIN AND CORTICOSTEROID
An inhalable formulation containing SAE-CD and corticosteroid is provided. The formulation is adapted for administration to a subject by nebulization with any...
2018/0154014 BETA-1,6-GLUCAN CETUXIMAB ANTIBODY CONJUGATES
The present invention encompasses embodiments in which cetuximab or a related cetuximab antibody is conjugated to .beta.-1,6-glucan oligomers. Thus, the...
2018/0154013 ABERRANT CELL-RESTRICTED IMMUNOGLOBULINS PROVIDED WITH A TOXIC MOIETY
Described are immunoglobulins provided with a toxic moiety, comprising at least an immunoglobulin variable region that specifically binds to an MHC-peptide...
2018/0154012 CANCER IMMUNOTHERAPEUTIC
The invention relates to immunotherapeutic compositions and methods for treating specifically solid tumours and cells of the tumour microenvironment.
2018/0154011 SELF-STABILIZING LINKER CONJUGATES
The present invention provides Ligand-Drug Conjugates, Drug-Linkers, Linkers, and Ligand-Linker Conjugates comprising a self-stabilizing linker assembly...
2018/0154010 Multivalent Meningococcal Polysaccharide-Protein Conjugate Vaccine
The present invention describes a combined vaccine that offers broad protection against meningococcal disease caused by the pathogenic bacteria Neisseria...
2018/0154009 INJECTABLE THERMORESPONSIVE POLYELECTROLYTES
Provided herein are compositions, devices, and systems comprising thermoresponsive, biodegradable elastomeric materials, and methods of use and manufacture...
2018/0154008 METHODS OF TREATMENT WITH ARGININE DEIMINASE
The present invention relates generally to methods of treating cancer with arginine deiminase, and in particular pegylated arginine deiminase.
2018/0154007 Glycemic Control Using Intrinsic Factor Bound to A Vitamin B12 Conjugate of a Glucagon-Like Peptide-1 Receptor...
The present invention provides compositions and methods for lowering blood glucose. More specifically, the present invention provides compositions comprising a...
2018/0154006 LIGAND IONOPHORE CONJUGATES
The invention described herein pertains to ligand-ionophore conjugates, that may also comprise a linked therapeutic agent or imaging agent, and pharmaceutical...
2018/0154005 CONJUGATES COMPRISING AN GLP-1/GLUCAGON DUAL AGONIST, A LINKER AND HYALURONIC ACID
The present invention relates to a conjugate or a pharmaceutically acceptable salt thereof comprising an GLP-1/Glucagon receptor agonist, a linker and a...
2018/0154004 Non-Gelatin Vaccine Protectant Composition and Live Attenuated Influenza Vaccine
The present invention provides a composition for use as the protectant for a live attenuated influenza virus vaccine, comprising the following components at...
2018/0154003 HYDROGEL COMPOSITIONS
Fragmented polysaccharide based hydrogel compositions and methods of making and using the same are provided. The subject polysaccharide based hydrogel...
2018/0154002 ABUSE-PROOF SOLID PHARMACEUTICAL COMPOSITION
The present invention relates to an abuse-proof solid pharmaceutical composition comprising an active ingredient with potential for abuse, silica in an amount...
2018/0154001 SUSTAINED DELIVERY FORMULATIONS OF RISPERIDONE COMPOUND
The present invention relates to a risperidone sustained release delivery system for treatment of medical conditions relating to delusional psychosis,...
2018/0154000 SUSTAINED RELEASE FORMULATION AND TABLETS PREPARED THEREFROM
Disclosed are formulations and tablets made therefrom comprising the compound of Formula IA or Formula IB which have sustained-release properties, and the...
2018/0153999 Dosing Regimens For The Treatment Of Fabry Disease
The presently disclosed subject matter provides a dosing regimen and administration schedule for the use of 1-deoxygalactonojirimycin and enzyme replacement...
2018/0153998 NOVEL PHARMACEUTICAL DOSAGE FORMS COMPRISING VALGANCICLOVIR HYDROCHLORIDE
The present invention provides novel solid pharmaceutical dosage forms for oral administration, after being constituted in water. The solid dosage forms...
2018/0153997 Liquid Protein Formulations Containing Organophosphates
Concentrated, low-viscosity, low-volume liquid pharmaceutical formulations of proteins have been developed. Such formulations can be rapidly and conveniently...
2018/0153996 DRY POWDER FORMULATIONS AND METHODS FOR TREATING PULMONARY DISEASES
The present invention is directed toward respirable dry particles for delivery of divalent metal cation salts and/or monovalent cation salts to the respiratory...
2018/0153995 USE OF ANTIMICROBIAL POLYMERS FOR RE-SENSITIZATION OF MICROORGANISMS UPON EMERGENCE OF RESISTANCE TO...
Methods and compositions for treating microbial infections associated with an emergence of resistance of a pathogenic microorganism to an antimicrobial agent,...
2018/0153994 BLOCKING IL-9 SIGNALING IN CONJUNCTION WITH CHEMOTHERAPY TO TREAT CANCER
This document provides methods and materials related to using inhibitors of IL-9 signaling in conjunction with chemotherapy to treat cancer (e.g., solid...
2018/0153993 COMPOSITIONS AND METHODS FOR TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES
The present invention provides novel methods for the prevention and treatment of cardiovascular diseases and inflammatory diseases by modulating the Hippo-YAP...
2018/0153992 METHODS FOR TARGETING OR STIMULATING CELLS OR ORGANISMS USING NANOPARTICLES AND EXTERNAL FIELD
This invention presents methods for targeting and killing types of cells or organisms using Magneto-Electric Nano-Particles under the control of an external...
2018/0153991 METHOD FOR THE TREATMENT OR PREVENTION OF INFECTION-RELATED IMMUNE CONDITIONS USING A COMPOSITION COMPRISING IGM
Embodiments of the present invention provide methods for the treatment or prevention of infection-related immune conditions using compositions comprising IgM.
2018/0153990 PCA1 PROTEIN AND METHODS OF TREATING PNEUMOCYSTIS PNEUMONIA INFECTION
The present invention relates to a method of treating Pneumocystis pneumonia infection in a subject. This method involves administering to a subject having a...
2018/0153989 COMPOSITIONS AND METHODS RELATED TO CELL SYSTEMS FOR PENETRATING SOLID TUMORS
The present disclosure provides, e.g., compositions and method for treating cancers, e.g., solid tumors. In embodiments, the compositions comprise an erythroid...
2018/0153988 HIGHLY CONCENTRATED LOW VISCOSITY MASP-2 INHIBITORY ANTIBODY FORMULATIONS, KITS, AND METHODS
The present invention relates to stable, high-concentration low-viscosity formulations of MASP-2 inhibitory antibodies, kits comprising the formulations and...
2018/0153987 TUMOUR NECROSIS FACTOR RECEPTOR FUSION PROTEINS AND METHODS OF USING THE SAME
A chimeric fusion polypeptide is provided comprising an extracellular domain of a canine TNF receptor p60 or p80 polypeptide conjoined to an Fc region of a...
2018/0153986 INTERACTIONS BETWEEN CEACAM AND TIM FAMILY MEMBERS
Described herein are compositions and methods for modulating immune response, which can be upregulated or down regulated by enhancement or inhibition of...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.